• LAST PRICE
    45.4900
  • TODAY'S CHANGE (%)
    Trending Down-0.7700 (-1.6645%)
  • Bid / Lots
    45.3900/ 1
  • Ask / Lots
    45.5600/ 4
  • Open / Previous Close
    46.0600 / 46.2600
  • Day Range
    Low 45.3000
    High 46.5600
  • 52 Week Range
    Low 29.2350
    High 53.0500
  • Volume
    58,678
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 46.26
TimeVolumeVCEL
09:32 ET663746.305
09:38 ET10046.185
09:39 ET30046.04
09:48 ET10045.81
09:50 ET121745.83
09:52 ET10045.87
09:54 ET115945.87
09:56 ET57445.875
09:57 ET58946.17
09:59 ET10046.1
10:03 ET40545.99
10:06 ET10045.96
10:08 ET30045.78
10:12 ET10045.855
10:14 ET10045.835
10:15 ET100045.77
10:17 ET90045.71
10:19 ET105945.65
10:21 ET30045.65
10:24 ET70045.47
10:26 ET470045.4
10:28 ET244945.5
10:30 ET80045.475
10:32 ET28245.529
10:33 ET80045.4214
10:35 ET65545.425
10:37 ET50045.36
10:39 ET100045.48
10:42 ET10045.415
10:44 ET50045.415
10:46 ET780745.38
10:48 ET50045.33
10:50 ET40045.3
10:51 ET160045.37
10:53 ET20045.415
10:55 ET110045.48
10:57 ET60045.49
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVCEL
Vericel Corp
2.2B
-665.2x
---
United StatesTGTX
TG Therapeutics Inc
2.1B
1,019.8x
---
United StatesARVN
Arvinas Inc
2.3B
-5.2x
---
United StatesIMCR
Immunocore Holdings PLC
2.7B
-47.5x
---
United StatesDNA
Ginkgo Bioworks Holdings Inc
1.8B
-2.0x
---
United StatesRYTM
Rhythm Pharmaceuticals Inc
2.3B
-12.2x
---
As of 2024-04-18

Company Information

Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The Company also holds a license for North American rights to NexoBrid (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for the removal of eschar in adults with deep partial-thickness and/or full-thickness burns.

Contact Information

Headquarters
64 Sidney StCAMBRIDGE, MA, United States 02139-4170
Phone
734-930-5555
Fax
734-665-0485

Executives

Independent Chairman of the Board
Robert Zerbe
President, Chief Executive Officer, Director
Dominick Colangelo
Chief Financial Officer
Joseph Mara
Chief Operating Officer
Michael Halpin
Senior Vice President, General Counsel, Secretary
Sean Flynn

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.2B
Revenue (TTM)
$197.5M
Shares Outstanding
48.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.74
EPS
$-0.07
Book Value
$4.72
P/E Ratio
-665.2x
Price/Sales (TTM)
11.3
Price/Cash Flow (TTM)
1,428.3x
Operating Margin
-3.27%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.